Navigation Links
Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep Disorders
Date:6/27/2011

SEATTLE, June 27, 2011 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today reported that it has identified compounds that interact with orphan G protein-coupled receptors (GPCRs) P2Y8 and OPN4. P2Y8 (also known as P2RY8) is associated with acute lymphoblastic leukemia (ALL), an aggressive cancer of the white blood cells. ALL is the most common type of malignancy diagnosed in children. The OPN4 receptor is involved with regulation of circadian rhythms, and could provide a target for drugs to improve alertness and to treat a wide range of sleep disorders ranging from narcolepsy and jet lag to insomnia.

Omeros has now announced that it has unlocked 10 of the 81 Class A orphan GPCRs. GPCRs represent the premier family of drug targets, with more than 30 percent of currently marketed drugs targeting only 46 GPCRs. There are approximately 120 orphan GPCRs, and Omeros, which expects to unlock a large percentage of these for drug development, is initially targeting Class A orphan GPCRs.

"The P2Y8 and OPN4 receptors are linked to important therapeutic areas that receive significant industry attention," said Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros. "By identifying compounds that interact with these two orphan receptors, our proprietary screening technology has opened previously closed drug-development pathways for ALL and sleep disorders."

Ongoing GPCR Program

Omeros has begun screening orphan GPCRs against its small-molecule chemical libraries using its proprietary, high-throughput cellular redistribution assay (CRA). Omeros has announced that it has identified and confirmed sets of compounds that interact selectively with 10 orphan receptors linked to squamous cell carcinoma (GPR87), pancreatic cancer (GPR182),acute lymphoblastic leukemia (P2Y8/P2RY8), metabolic and psychotic disorders(GPR27, GPR85, GPR173), appetite c
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros Reports Allowance of Additional Patent for Arthroscopic Product
2. Omeros Announces Clinical Development Programs for OMS103HP and OMS302
3. Omeros Corporation Reports First Quarter 2011 Financial Results
4. Omeros Announces Expansion of Potential Indications for PDE7 Inhibitors
5. Omeros Announces Publication of MASP-2 Data in Proceedings of the National Academy of Sciences
6. Omeros Reports Outcome of Phase 3 Trials of OMS103HP
7. Omeros Corporation Reports Fourth Quarter and Year-End 2010 Financial Results
8. Omeros Unlocks Orphan GPCRs Linked to Pancreatic Cancer and Cognitive Disorders
9. Omeros Announces Expansion of Exclusive License to PDE7 Inhibitors from Daiichi Sankyo
10. Omeros Announces Publication of Data From Antifibrinolytic Program
11. Omeros Licenses Novel Antifibrinolytic Agents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)...  Vivex Biomedical, Inc., a leading processor of human ... today that it hired Lou Barnes as ... Vivex Biomedical formed UMTB Biomedical as a wholly-owned subsidiary ... in November 2014. UMTB is the oldest tissue bank ... twenty-five year veteran of the tissue banking industry, having ...
(Date:3/2/2015)... -- Akron Children,s Hospital has been designated a Diagnostic Imaging ... Radiology (ACR), making it the first hospital in ... in the United States to ... the ACR as a DICOE provides validation that our ... national benchmarks," says Dr. Michael Rubin , chairman, ...
(Date:3/2/2015)... 2, 2015  Kush Bottles, North ... solutions for the marijuana industry, announced today that ... been nominated for a 2015 Excellence in Entrepreneurship ... Award is designed to recognize individuals who exemplify ... their creativity and determination, have established and nurtured ...
Breaking Medicine Technology:Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 2Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 3Akron Children's designated ACR Diagnostic Imaging Center of Excellence 2Kush Bottles CEO, Nicholas Kovacevich, Nominated for 2015 "Excellence in Entrepreneurship Award" 2
(Date:3/2/2015)... Wants and Needs ” was featured on NewsWatch as ... and coolest mobile applications on the iOS, Android, and ... host of NewsWatch, conducted the app review and shared ... , Whether a person needs help re-orienting or prioritizing ... allows people to enter and track wants, both good ...
(Date:3/2/2015)... 2015 Doctors in Novara, Italy have ... predictor of outcomes for people with mesothelioma than other ... of the new study on the Surviving Mesothelioma website. ... of Eastern Piedmont followed the cases of 172 ... excess lung fluid. , “Persistent lung expansion after ...
(Date:3/2/2015)... Robins & Morton Celebrates Women In Construction , ... Week (March 1-7, sponsored by the National Association of ... Month, Robins & Morton is recognizing several women whose ... construction industry as a whole. From the craft professionals, ... in between, each woman has a story to share. ...
(Date:3/2/2015)... March 02, 2015 New York ... Unplugged™—will be delivering a plenary address entitled Finding ... the Art of Healing and Recovery at this ... Behavioral Healthcare Executive Summit (BHES).     , With more ... songs have been recorded by some of the ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Representatives ... it has officially launched a multivitamin supplement that’s ... of product development for BNatrl, said the multivitamin, ... from Olympic and other world-class athletes. , "Being ... use this pure whole food multivitamin to improve ...
Breaking Medicine News(10 mins):Health News:An Application to Evaluate Priorities Was Featured on NewsWatch Television on January 30, 2015 2Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Robins & Morton Recognizes Women In Construction 2Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2Health News:Bnatrl Launches Multivitamin Supplement for Runners 2
... FindingsBAYSIDE, N.Y., May 28 Once every five ... and medical experts on Tourette Syndrome (TS) -- ... and sounds -- convene to disseminate and share ... condition.As part of its basic mission to identify ...
... than 20 pounds , , THURSDAY, May 28 (HealthDay News) ... pregnancy to between 11 and 20 pounds to safeguard ... newly updated expert guidelines. , That level of gestational ... pregnant women and reflects the concern over the rising ...
... Associate Professor and Director of Biomaterials Research at ... Dentistry, has been awarded a grant in the ... the National Institutes of Health to develop new ... composites, bonding agents, and sealants. Currently most dental ...
... TRAVERSE CITY, Mich., May 28 Versus Technology, Inc. ("Versus" or ... for its second fiscal quarter ended April 30, 2009, a ... quarter of the prior year. Revenues for the six ... for the six months ended April 30, 2008, a 3.5% ...
... Inc. (Nasdaq: STRM ) today announced ... Company,s document workflow solutions will be integrated into ... within an additional leading Canadian healthcare region. Integrating ... view into a patient,s complete history of care ...
... 28 Aventis Pharmaceutical Inc., a wholly owned subsidiary of ... $95.5 million to settle allegations that it violated the False ... its Medicaid Drug Rebate obligations, the Justice Department announced today. ... The settlement resolves allegations that between 1995 ...
Cached Medicine News:Health News:5th International Scientific Symposium on Tourette Syndrome to Focus on Latest Research and Treatment 2Health News:5th International Scientific Symposium on Tourette Syndrome to Focus on Latest Research and Treatment 3Health News:Experts Urge Less Weight Gain for Obese Women in Pregnancy 2Health News:Experts Urge Less Weight Gain for Obese Women in Pregnancy 3Health News:Versus Technology Announces Second Quarter Results 2Health News:Versus Technology Announces Second Quarter Results 3Health News:Versus Technology Announces Second Quarter Results 4Health News:Versus Technology Announces Second Quarter Results 5Health News:Versus Technology Announces Second Quarter Results 6Health News:Versus Technology Announces Second Quarter Results 7Health News:Streamline Health Document Workflow Solution to be Integrated Into Electronic Medical Records System for Leading Canadian Healthcare Region 2Health News:Streamline Health Document Workflow Solution to be Integrated Into Electronic Medical Records System for Leading Canadian Healthcare Region 3Health News:Aventis Pharmaceutical to Pay U.S. $95.5 Million to Settle False Claims Act Allegations 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: